To explore the effect of MHBSt167-induced NF-κB activation on HCC development, the NF-κB pathway inhibitor BAY-11–7082 was used in L02 cells expressing MHBSt167. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.